Carregant...
The Importance of STK11/LKB1 Assessment in Non-Small Cell Lung Carcinomas
Despite the recent implementation of immunotherapy as a single treatment or in combination with chemotherapy for first-line treatment of advanced non-small cell lung cancer (NSCLC), many patients do not benefit from this regimen due to primary treatment resistance or toxicity. Consequently, there is...
Guardat en:
| Publicat a: | Diagnostics (Basel) |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7912095/ https://ncbi.nlm.nih.gov/pubmed/33572782 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diagnostics11020196 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|